[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:bone-sarcoma":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":68,"states":69},"Bone Sarcoma",9,7,[8,16,23,29,35,41,47,53,60],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT05621668","A First-In-Human Phase 1 Trial of T-Cell Membrane-Anchored Tumor Targeted Il12 (Attil12)- T-Cell Therapy in Subjects With Advanced\u002FMetastatic Soft Tissue and Bone Sarcoma",[12],"Phase 1","RECRUITING","2026-08-03T02:56:00.496454Z","2026-05-05T02:43:29.232388Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT07193550","A Phase 2 Trial of Zanzalintinib in Advanced\u002FMetastatic Bone Sarcomas (ZAMBONE)",[20],"Phase 2","2026-08-26T02:16:35.654046Z","2026-05-05T02:43:28.850363Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT06474676","T Cell Membrane-Anchored Tumor-Targeted IL12 -Modified TIL Cell Therapy (attIL12-TIL) for Advanced\u002FMetastatic Soft Tissue and Bone Sarcoma Patients.",[12],"2026-08-26T02:16:31.714843Z","2026-05-05T02:43:27.639815Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT06571734","XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma, Bone Sarcoma or Translocation-associated Soft Tissue Sarcoma",[20],"2026-08-26T02:17:14.343713Z","2026-07-05T05:32:16.766529Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":39,"content_modified":40},"NCT06129903","Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With Sarcoma",[],"2026-08-26T02:15:02.712396Z","2026-04-29T02:57:57.068659Z",{"nct_id":42,"title":43,"phases":44,"status":13,"updated_at":45,"content_modified":46},"NCT07215611","Financial Toxicity in Patients With Resected Soft Tissue and Bone Sarcomas",[],"2026-08-26T02:19:13.549512Z","2026-05-13T02:55:06.672015Z",{"nct_id":48,"title":49,"phases":50,"status":13,"updated_at":51,"content_modified":52},"NCT06409013","Evaluation of Tumor Resection Guided by Intraoperative Indocyanine Green Dye Fluorescence Angiography in Patients With Sarcoma",[],"2026-08-26T02:17:26.640202Z","2026-05-13T02:55:06.487811Z",{"nct_id":54,"title":55,"phases":56,"status":57,"updated_at":58,"content_modified":59},"NCT07662239","Bridging Adolescent and Young Adult Sarcoma Survivors With Personalized Oncology Exercise Service (AYA-ONE): A Pilot Intervention",[],"NOT_YET_RECRUITING","2026-08-26T02:18:40.612983Z","2026-07-05T03:45:20.260985Z",{"nct_id":61,"title":62,"phases":63,"status":65,"updated_at":66,"content_modified":67},"NCT03244020","LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology",[64],"Phase 4","ENROLLING_BY_INVITATION","2026-08-26T02:18:56.409949Z","2026-06-16T05:54:07.965326Z",[],[70],{"state":71,"count":72,"slug":73},"Texas",5,"texas"]